Exp Neurobiol (2017) 26:22739
From the PlexusDx Education Hub, our evidence-based resource on GLP-1 therapy, weight management, and the genetics that inform metabolic care
Pooled data from these three trials showed that rates of HF hospitalization were not significantly different between DPP-4i and placebo, suggesting that the effect may not be a class effect [100, 101]
From November 27 through December 1 , youll be able to move forward with the next step that feels right for you whether thats adding support, starting something new, or getting clarity through testing
Thankfully, theres a new class of drugs thats changing peoples lives for the better: GLP-1 agonists
"Whether we'd like to admit it or not, our appearance matters," says Sarwer